Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

SecondMarket to expand further into private company markets over next 6 months

Friday, July 08, 2011
Opalesque Industry Update – SecondMarket has grown 125% in the first half of 2011, and the firm expects to open yet another swath of companies to investors during the second half of the year. Hedge funds and other firms have been riding the latest tech bubble by utilizing SecondMarket to access equity at start up firms that have received venture capital.

Growing activity in private company investments
With over 67,000 individuals and institutions now on the SecondMarket platform the firm reports” increased engagement by participants in forming trusted investor networks and watching private companies and submitting interests to buy or sell alternative investments.”

In early June, SecondMarket’s Mark Murphy commented to Opalesque that many hedge funds were active in the tech industry stocks, and that “"In Q1 the companies that saw the biggest rate of increase in watchers [firms that SecondMarket users are tracking] were Foursquare, Dropbox, Spotify, Skype and Gilt Groupe.” (Source)

But the firm is also reporting increased activity interest in non-technology industries, and so SecondMarket CEO Barry Silbert announced in the firm’s Q2 2011 Business Update, that “We are continuing to explore the expansion of the private company market beyond venture-backed startups to include a broad array of established private companies. The team has identified a number of non-technology industries in which there is a strong interest for our company-controlled liquidity programs, and we are likely to launch the first liquidity program for an established company in the next six months.”

The Private Company Market team has also added three hires: Arie Abecassis, Matt Shapiro and Taylor Ridgely.

Kirsten Bischoff

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for